The diagnostic yield of next generation sequencing in inherited retinal diseases: a systematic review and meta-analysis

AC Britten-Jones, SA Gocuk, KL Goh, A Huq… - American Journal of …, 2023 - Elsevier
PURPOSE Accurate genotyping of individuals with inherited retinal diseases (IRD) is
essential for patient management and identifying suitable candidates for gene therapies …

Female carriers of X-linked inherited retinal diseases–Genetics, diagnosis, and potential therapies

SA Gocuk, JK Jolly, TL Edwards, LN Ayton - Progress in retinal and eye …, 2023 - Elsevier
Inherited retinal diseases (IRDs) are a group of heterogeneous conditions that cause
progressive vision loss, typically due to monogenic mutations. Female carriers of X-linked …

[PDF][PDF] Gene Editing for CEP290-Associated Retinal Degeneration

EA Pierce, TS Aleman, KT Jayasundera… - N. Engl. J …, 2024 - nueyecal.com
BACKGROUND CEP290-associated inherited retinal degeneration causes severe early-
onset vision loss due to pathogenic variants in CEP290. EDIT-101 is a clustered regularly …

Gene-based therapeutics for inherited retinal diseases

BJ Fenner, TE Tan, AV Barathi, SBB Tun… - Frontiers in …, 2022 - frontiersin.org
Inherited retinal diseases (IRDs) are a heterogenous group of orphan eye diseases that
typically result from monogenic mutations and are considered attractive targets for gene …

[HTML][HTML] Preclinical investigations on broccoli-derived sulforaphane for the treatment of ophthalmic disease

FAA Kwa, BV Bui, BR Thompson, LN Ayton - Drug Discovery Today, 2023 - Elsevier
Vision loss causes a significant burden on individuals and communities on a financial,
emotional and social level. Common causes include age-related macular degeneration …

Stem cell therapy for inherited retinal diseases: a systematic review and meta-analysis

X Chen, N Xu, J Li, M Zhao, L Huang - Stem Cell Research & Therapy, 2023 - Springer
Purpose Stem cell therapy is a promising therapeutic approach for inherited retinal diseases
(IRDs). This study aims to quantitatively examine the effectiveness and safety of stem cell …

Advances in ophthalmic optogenetics: approaches and applications

PP Prosseda, M Tran, T Kowal, B Wang, Y Sun - Biomolecules, 2022 - mdpi.com
Recent advances in optogenetics hold promise for vision restoration in degenerative eye
diseases. Optogenetics refers to techniques that use light to control the cellular activity of …

[HTML][HTML] The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: a systematic review

AC Britten-Jones, R Jin, SA Gocuk, E Cichello… - Genetics in …, 2022 - Elsevier
Purpose This study aimed to systematically review and summarize gene therapy treatment
for monogenic retinal and optic nerve diseases. Methods This review was prospectively …

Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single …

P Kiraly, CL Cottriall, LJ Taylor, JK Jolly… - Biomolecules, 2023 - mdpi.com
Our study evaluated the morphological and functional outcomes, and the side effects, of
voretigene neparvovec (VN) gene therapy for RPE65-mediated inherited retinal dystrophies …

Stargardt disease and progress in therapeutic strategies

D Huang, RC Heath Jeffery, MT Aung-Htut… - Ophthalmic …, 2022 - Taylor & Francis
Background Stargardt disease (STGD1) is an autosomal recessive retinal dystrophy due to
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …